Scientist by training, entrepreneur by instinct. Three decades building, scaling, and turning around companies across water technology, international trade, and regenerative medicine.
§ I. The story
Six dimensions
Trained in Homoeopathic Medicine, graduating with a Gold Medal. The degree gave something more durable than knowledge: a way of thinking. Observe first. Question the obvious. Find the root, not just the symptom. It is how I have approached every business since.
Founded and scaled a water-technology enterprise, including the region's largest packaged-drinking-water unit, a national franchise, and pioneering effluent and sewage treatment systems. The shape of a company is not theoretical to me.
Seven years as CEO of a publicly listed company's import/export division: iron-ore exports, commodity imports, and trade-finance structuring across geographies. P&L, customs, banks, freight, weather. The whole texture of cross-border business.
Co-founded a stem-cell and cord-blood venture, designing public and private banking models to put cord-blood units within reach of families across income levels. Conducted government-funded research with SIBRI, DBT, and BIRAC on stem-cell scaffolds, pre-clinically validated. Where rigorous science meets the obligation to reach people, not just institutions.
Independent practice today: AI-integrated management systems, GCC and Africa market entry, trade-finance structuring, and turnaround. Embedded with the team, focused on implementation.
Growth Memos and The Success Paradox are where I keep my notebook: three decades of operating turned into practical ideas about execution, systems, and the long horizon.
§ II. By the numbers
A handful of facts
§ III. Approach
Four engagement areas
I work alongside founders and operating teams: short, focused engagements with measurable outcomes, and an AI-integrated management approach that compounds month over month. The work is in the implementation, not the deck.
Diagnose the P&L, rebuild the operating cadence, install the systems, exit when the team owns it.
Go-to-market design, regulatory navigation, partner sourcing, and ground-truth on what actually works in these regions.
Structuring import/export flows, working-capital instruments, and counterparty risk on real-world cross-border deals.
Bringing scientific rigour to commercial design, from regenerative medicine to clinic networks to public-private models.
If the shape of the problem feels familiar,
Let's talk§ IV. Writing
Two notebooks
Short, useful notes, written for founders and operators in the trenches, not for management consultants.
A running essay on what success quietly costs, for people who have already won something and are starting to see what got traded for it along the way.
Read the essay§ V. Contact
For advisory engagements, speaking, or simply a thoughtful introduction, write directly. I read everything that lands here.
